Revolutionizing Safe & Potent Activation of TLR, STING & Other Innate Immunity Sensors to Target Solid Tumors, Optimize Clinical Approach & Supercharge Your Pipeline

Welcome to the 3rd Annual TLR & PRR-Targeted Therapies Summit

Plus Innate Immune Checkpoints & Activation Pre-Conference Focus Day

The 3rd TLR & PRR-Targeted Therapies Summit is coming at a timely inflection point in this field.

With multiple TLR agonists moving into the clinic, STING agonists exposing new challenges, multiple approvals on the horizon, and more novel targets & combinations currently undergoing exciting pre-clinical validation than ever before, this unique and highly anticipated industry-focused meeting will unite experts in innate immunity to overcome the barriers it faces and accelerate clinical breakthrough.

Returning in-person to the biopharma hub of Boston, 30+ expert speakers will take you through case-study led presentations, juicy panel discussions and live Q&A’s, all tailored to suit your TLR, STING & other PRR targeting needs.

Gain connections and insights to plan how to optimize the development of your innate immune agonists into the clinic and overcome obstacles that may impede the delivery of more selective, better-tolerated medicines to improve survival rates in difficult-to-treat cancers.

View the event guide now for the full agenda.

150+ Reasons to Join in 2022:

  • 100+ key decision makers from across the TLR, PRR & innate immune sensory landscape
  • 30+ industry expert speakers providing you with the latest and greatest insights from this field, all under one roof
  • 20+ hours of content exploring the latest preclinical & clinical advancements to help optimise your approaches and advance your pipeline
  • 4+ hours of dedicated networking time to make new connections, ask your questions and benchmark against your industry
  • 1 pre-conference focus day deep diving into innate subsets during checkpoint blockade to develop combination therapies to help overcome checkpoint resistance

2022 Speakers Include:

What Will You Learn?

STING & TLR Favicon

Clinical progress with innate immune-targeting compounds

STING & TLR Favicon

Rationale & progress in targeting different TLRs

STING & TLR Favicon

Developing predictive preclinical models in PRR research to achieve human-specific translation

STING & TLR Favicon

Exploring the emerging targets in PRR-targeting: strategy, execution, development & promise

STING & TLR Favicon

Optimizing clinical trial design for innate immunotherapy drug development

STING & TLR Favicon

Optimizing your PRR-based drug delivery technology

STING & TLR Favicon

Analysing & optimizing the various drug format options

STING & TLR Favicon

Next steps in PRR combination interventions - to heighten drug effect & overcome resistance - the future?

Who Attended in 2021?

Proud to Partner With:

The health, safety and well-being of our community remains our highest priority. Therefore, all attendees will be required to complete a health declaration prior to attending the event. As part of this, attendees must declare that they are either fully vaccinated and /or have completed a negative Lateral Flow Test or PCR Test within 48 hours the event*. For further information around Health and Safety onsite, please visit our FAQ here.

*Please note, this is subject to change at any time without prior notice.